Foghorn Therapeutics, Inc. (FHTX) Social Stream
Foghorn Therapeutics Inc (FHTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Foghorn Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
FHTX's average price target has moved up $3.67 over the prior 112 days.
FHTX reports an average of 116.3% for its upside potential over the past 48 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
FHTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 151 days, FHTX's average broker recommendation rating improved by 0.5.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FHTX as an investment opportunity.
- FHTX has a greater number of analysts covering the stock than 79.48% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Foghorn Therapeutics Inc's variance in analysts' estimates is lower than 31.07% of them.
- Foghorn Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 124.67% of Pharmaceutical Products stocks.
- In terms of how Foghorn Therapeutics Inc fares relative to Healthcare stocks, note that its average analyst price target is higher than 200.25% of that group.
In the Pharmaceutical Products industry, FBRX, FBIO, and EWTX are the three stocks most similar to Foghorn Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is FHTX a Buy, Hold or Sell? See the POWR Ratings now!